Cami M P Talavera Ormeño (Cami Talavera Ormeño)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Methicillin Resistant Staphylococcus Aureus

Pluripotent Stem Cells

Top Venues

European journal of immunology

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

This page only lists publications with an associated author ORCID identifier.

Publications

Josien Lanfermeijer, Koen van de Ven, Harry van Dijken, Marion Hendriks, Cami M P Talavera Ormeño, Femke de Heij, Paul Roholl, José A M Borghans, Debbie van Baarle, Jaime Jesús Pérez
Modified influenza M1 58-66 peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge. NPJ vaccines 8 (1) (2023)
Matevž Rumpret, Helen J von Richthofen, Maarten van der Linden, Geertje H A Westerlaken, Cami M P Talavera Ormeño, Jos A G van Strijp, Meytal Landau, Huib Ovaa, Nina M van Sorge, Linde Meyaard
Signal inhibitory receptor on leukocytes-1 recognizes bacterial and endogenous amphipathic α-helical peptides. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 35 (10) (2021)
Matevž Rumpret, Helen J von Richthofen, Maarten van der Linden, Geertje H A Westerlaken, Cami M P Talavera Ormeño, Teck Yew Low, Huib Ovaa, Linde Meyaard
Recognition of S100 proteins by Signal Inhibitory Receptor on Leukocytes-1 negatively regulates human neutrophils. European journal of immunology 51 (9) (2021)